Clinical Trial Update: Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial update reports dose escalation and expansion of Ziftomenib in combination with Quizartinib for Acute Myeloid Leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Quizartinib (Quizartinib)
• Ziftomenib (ziftomenib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: RECRUITING